John Kotter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
John Kotter has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Paul Anaya
Department of Internal Medicine, Gill Heart Institute, University of Kentucky , Lexington, KY , USA
2 shared publications - Vincent L. Sorrell
Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
2 shared publications - Andrew C. T. Ha
Peter Munk Cardiac Centre, University Health Network, Toronto
1 shared publication Anna Woo
Versailles, Kentucky
1 shared publication- Brian P. Delisle
University of Kentucky
1 shared publication Bryan Dias
Versailles, Kentucky
1 shared publication
Latest Publications
- Open Access
- 7 August 2025
- Published by IOS Press
- Vol. 329, 1742-1743
A Co-Designed and Theory-Based Mobile Health App for Patients with Postural Orthostatic Tachycardia Syndrome (POTS): Development and Usability Testing
Postural Orthostatic Tachycardia Syndrome (POTS) patients experience debilitating symptoms and struggle to obtain a timely diagnosis. Mobile health (mHealth) and wearable technology may provide health information to empower patients when communicating with providers and in turn shorten the time to diagnosis. We conducted three online co-design focus groups with POTS patients to determine elements of a desirable mHealth intervention. Themes emerged that helped us develop a smartphone- and wearable-based system, using a risk communication model as a message design framework. A pilot randomized trial is ongoing to test the POTS App. Initial results showed the app reaches high usability.
- 7 August 2025
- Published by IOS Press
- Vol. 329, 1742-1743
Open AccessA Co-Designed and Theory-Based Mobile Health App for Patients with Postural Orthostatic Tachycardia Syndrome (POTS): Development and Usability Testing
Postural Orthostatic Tachycardia Syndrome (POTS) patients experience debilitating symptoms and struggle to obtain a timely diagnosis. Mobile health (mHealth) and wearable technology may provide health information to empower patients when communicating with providers and in turn shorten the time to diagnosis. We conducted three online co-design focus groups with POTS patients to determine elements of a desirable mHealth intervention. Themes emerged that helped us develop a smartphone- and wearable-based system, using a risk communication model as a message design framework. A pilot randomized trial is ongoing to test the POTS App. Initial results showed the app reaches high usability.
- Open Access
- 7 February 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (3) , 828-834
A stepwise external cardioversion protocol for atrial fibrillation to maximize acute success rate
Cardioversion is a very commonly performed procedure for persistent atrial fibrillation (AF). However, there is no well-defined protocol to address failed external electrical direct current cardioversion. The aim of the study is to test the efficacy of a pre-defined stepwise cardioversion protocol for patients with persistent AF of ≤12 months. Success was the achievement of sinus rhythm. The study population included patients with persistent AF of ≤12 months duration requiring rhythm management. Patients were offered cardioversion using a pre-defined stepwise protocol using different electrode placement locations, applying compression at end of expiration, and higher energy delivered simultaneously through two defibrillators. : A total of 414 patients were included in the study, of which 362 (87.4%) required a single successful cardioversion. The remaining 52 (12.5%) patients required additional cardioversion attempts using the stepwise cardioversion protocol with an overall success rate of 99.3%. Two simultaneous defibrillators were required in 14 patients (3.4%). Patients with multiple cardioversions (13.5%) experienced more local skin irritation and pain compared with patients with single cardioversion (13.5% vs. 3.5%, P = 0.004). The predictor for the need for multiple cardioversion attempts is high body mass index, while high transthoracic impedance is associated with failed cardioversion. No major complications were observed during the study. The stepwise cardioversion protocol has a high success rate of >99% and can be safely performed in outpatient or inpatient settings.
- 7 February 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (3) , 828-834
Open AccessA stepwise external cardioversion protocol for atrial fibrillation to maximize acute success rate
Cardioversion is a very commonly performed procedure for persistent atrial fibrillation (AF). However, there is no well-defined protocol to address failed external electrical direct current cardioversion. The aim of the study is to test the efficacy of a pre-defined stepwise cardioversion protocol for patients with persistent AF of ≤12 months. Success was the achievement of sinus rhythm. The study population included patients with persistent AF of ≤12 months duration requiring rhythm management. Patients were offered cardioversion using a pre-defined stepwise protocol using different electrode placement locations, applying compression at end of expiration, and higher energy delivered simultaneously through two defibrillators. : A total of 414 patients were included in the study, of which 362 (87.4%) required a single successful cardioversion. The remaining 52 (12.5%) patients required additional cardioversion attempts using the stepwise cardioversion protocol with an overall success rate of 99.3%. Two simultaneous defibrillators were required in 14 patients (3.4%). Patients with multiple cardioversions (13.5%) experienced more local skin irritation and pain compared with patients with single cardioversion (13.5% vs. 3.5%, P = 0.004). The predictor for the need for multiple cardioversion attempts is high body mass index, while high transthoracic impedance is associated with failed cardioversion. No major complications were observed during the study. The stepwise cardioversion protocol has a high success rate of >99% and can be safely performed in outpatient or inpatient settings.
- Open Access
- 1 July 2020
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 33 (7) , A1-A6
Table of Contents
- 1 July 2020
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 33 (7) , A1-A6
Open AccessTable of Contents
- 1 March 2019
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 663, 129-131
Closing the therapeutic loop
- 1 March 2019
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 663, 129-131
Closing the therapeutic loop